Doing the hiring is a good point. I think you're really underestimating the worth of the company though.We should be trading at least at 5 right now. That would put us at half the market cap of el crapola supremo AXON, whose market cap is 1.2 Billion, for its one drug which is a failed Alzheimer's drug that was abandoned by Sanofi and sold to them for 5 million.
Compare what our 5 million for Brilacidin bought us, as opposed to one failed Alz drug that goes down the same failed pathway as all the other non-efficacious drugs. Leo got us a lot more bang for the buck.
Any time those jerks start bashing Leo, all anyone should have to say is, "He bought Brilacidin for 5 million bucks."
Compare what our 5 million for Brilacidin bought us, as opposed to one failed Alz drug that goes down the same failed pathway as all the other non-efficacious drugs. Leo got us a lot more bang for the buck.
Any time those jerks start bashing Leo, all anyone should have to say is, "He bought Brilacidin for 5 million bucks."